[go: up one dir, main page]

SG152233A1 - Benzoxazine for treating respiratory tract diseases - Google Patents

Benzoxazine for treating respiratory tract diseases

Info

Publication number
SG152233A1
SG152233A1 SG200902504-0A SG2009025040A SG152233A1 SG 152233 A1 SG152233 A1 SG 152233A1 SG 2009025040 A SG2009025040 A SG 2009025040A SG 152233 A1 SG152233 A1 SG 152233A1
Authority
SG
Singapore
Prior art keywords
benzoxazine
respiratory tract
treating respiratory
tract diseases
diseases
Prior art date
Application number
SG200902504-0A
Other languages
English (en)
Inventor
Thierry Bouyssou
Ingo Konetzki
Sabine Pestel
Andreas Schnapp
Christoph Hoenke
Philipp Lustenberger
Klaus Rudolf
Kurt Schromm
Frank Buettner
Claudia Heine
Hermann Schollenberger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of SG152233A1 publication Critical patent/SG152233A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SG200902504-0A 2004-04-22 2005-04-18 Benzoxazine for treating respiratory tract diseases SG152233A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004019539A DE102004019539A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittel zur Behandlung von Atemwegserkrankungen

Publications (1)

Publication Number Publication Date
SG152233A1 true SG152233A1 (en) 2009-05-29

Family

ID=34966948

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200902504-0A SG152233A1 (en) 2004-04-22 2005-04-18 Benzoxazine for treating respiratory tract diseases

Country Status (20)

Country Link
EP (1) EP1765355B1 (ru)
JP (1) JP2007533684A (ru)
KR (2) KR20130042662A (ru)
CN (1) CN1946406A (ru)
AU (1) AU2005235420C1 (ru)
BR (1) BRPI0510084A (ru)
CA (1) CA2559700C (ru)
DE (1) DE102004019539A1 (ru)
DK (1) DK1765355T3 (ru)
EA (1) EA012045B1 (ru)
EC (1) ECSP066948A (ru)
ES (1) ES2403184T3 (ru)
IL (1) IL177663A (ru)
NO (1) NO20065061L (ru)
NZ (1) NZ551272A (ru)
PL (1) PL1765355T3 (ru)
SG (1) SG152233A1 (ru)
UA (1) UA85707C2 (ru)
WO (1) WO2005102350A1 (ru)
ZA (1) ZA200606547B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
PL1917253T3 (pl) 2005-08-15 2015-06-30 Boehringer Ingelheim Int Sposób wytwarzania betamimetyków
JP2009514933A (ja) * 2005-11-09 2009-04-09 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 吸入用エアロゾル製剤
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
EP2231642B1 (en) 2008-01-11 2013-10-23 Novartis AG Pyrimidines as kinase inhibitors
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8637516B2 (en) 2010-09-09 2014-01-28 Irm Llc Compounds and compositions as TRK inhibitors
PH12013501758A1 (en) 2011-02-25 2013-10-14 Irm Llc Pyrazolo [1,5-a] pyridines as trk inhibitors
WO2014108449A1 (en) 2013-01-08 2014-07-17 Atrogi Ab A screening method, a kit, a method of treatment and a compound for use in a method of treatment
EP3551187B1 (en) 2016-12-12 2021-02-17 Boehringer Ingelheim International GmbH Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with olodaterol
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB202205895D0 (en) 2022-04-22 2022-06-08 Atrogi Ab New medical uses
WO2024153813A1 (en) 2023-01-20 2024-07-25 Atrogi Ab Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting
GB202302225D0 (en) 2023-02-16 2023-04-05 Atrogi Ab New medical uses
GB202303229D0 (en) 2023-03-06 2023-04-19 Atrogi Ab New medical uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
EA200201056A1 (ru) * 2000-04-27 2003-04-24 Бёрингер Ингельхайм Фарма Кг Новые, обладающие продолжительным действием бетамиметики, способ их получения и их применение в качестве лекарственных средств
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
DE102004019539A1 (de) 2005-11-10
JP2007533684A (ja) 2007-11-22
UA85707C2 (ru) 2009-02-25
BRPI0510084A (pt) 2007-10-16
KR20130042662A (ko) 2013-04-26
WO2005102350A1 (de) 2005-11-03
EA012045B1 (ru) 2009-08-28
CA2559700A1 (en) 2005-11-03
CN1946406A (zh) 2007-04-11
KR101338947B1 (ko) 2013-12-10
ZA200606547B (en) 2008-04-30
AU2005235420A1 (en) 2005-11-03
NO20065061L (no) 2006-11-07
EA200601837A1 (ru) 2007-04-27
AU2005235420C1 (en) 2011-02-24
ECSP066948A (es) 2006-12-20
EP1765355B1 (de) 2013-03-06
DK1765355T3 (da) 2013-04-08
ES2403184T3 (es) 2013-05-16
PL1765355T3 (pl) 2013-08-30
IL177663A0 (en) 2006-12-31
AU2005235420B2 (en) 2010-10-28
KR20070054599A (ko) 2007-05-29
NZ551272A (en) 2010-10-29
EP1765355A1 (de) 2007-03-28
CA2559700C (en) 2013-06-11
IL177663A (en) 2014-04-30

Similar Documents

Publication Publication Date Title
SG152233A1 (en) Benzoxazine for treating respiratory tract diseases
HUS1500058I1 (hu) Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére
HK1087360A1 (en) Patient oxygen delivery mask
EP1742641A4 (en) METHODS AND COMPOSITIONS FOR DETECTION AND TREATMENT OF RETINA DISEASES
AU301937S (en) Elbow for mask
AU2003903139A0 (en) Breathable gas apparatus with humidifier
IL179906A0 (en) Novel hydantoin derivatives for the treatment of obstructive airway diseases
ZA200610640B (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
HK1119592A1 (en) Interferon lambda therapy for treatment of respiratory diseases
IL185444A0 (en) Novel drugs for treating respiratory diseases
IL197125A0 (en) Drug combinations for treating airway diseases
AU302570S (en) Elbow for mask
TW200631584A (en) A medicament related to mirtazapine for the treatment of hot flush
GB0428218D0 (en) Medicament for Treatment of Inflammatory Diseases
ZA200606780B (en) Compounds for the treatment of diseases
AU303175S (en) Elbow for respiratory mask
AU2004901008A0 (en) Breathable Gas Apparatus with Humidifier
EP1776976B8 (de) Inhalationsgerätekompressor für eine Inhalationstherapievorrichtung
AP2006003728A0 (en) Compounds for treatment of diseases
HU0600490D0 (en) Medical use of chelidonium mejs, gacid, cinadane
GB0616858D0 (en) Patient expired anaesthetic gas scavenging apparatus
GB0425073D0 (en) Compounds for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
HU3048U (en) Feeder instrument especially for medical treating vagina